12.07.2015 Views

What Works for Women and Girls

What Works for Women and Girls

What Works for Women and Girls

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>What</strong> <strong>Works</strong>—Prevention <strong>for</strong> Key Affected Populations: <strong>Women</strong> Drug Users <strong>and</strong> FemalePartners of Male IDUs1. Opioid substitution therapy, particularly maintenance programs with methadone<strong>and</strong> buprenorphine, leads to reduction in HIV risk behavior among male <strong>and</strong> femaleIDUs, <strong>and</strong> is safe <strong>and</strong> effective <strong>for</strong> use by pregnant women.2. Comprehensive harm reduction programs, including needle exchange programs,condom distribution, substitution therapy <strong>and</strong> outreach, can reduce HIV riskbehaviors <strong>and</strong> prevalence among male <strong>and</strong> female IDUs.3. Peer education can increase protective behaviors among IDUs.4. Instituting harm reduction programs <strong>for</strong> IDUs in prisons can reduce HIV prevalencein female prison populations.Promising Strategies:5. Sex-segregated group sessions <strong>for</strong> IDUs can result in increased condom use <strong>and</strong> safeinjection behaviors.6. <strong>Women</strong>’s clubs along with peer education <strong>and</strong> condom distribution can reduce HIVprevalence among women who are sexual partners of male IDUs.7. Nonjudgmental targeted counseling <strong>for</strong> IDUs can reduce HIV risk behaviors.8. Increased access to voluntary HIV counseling <strong>and</strong> testing to learn one’s serostatusmay reduce needle sharing <strong>and</strong> other HIV risk behaviors.9. Programming to prevent initiation of injecting drug use shows promise in reducingthe number of IDUs <strong>and</strong> associated HIV risk behaviors.EVIDENCE1. Opioid substitution therapy, particularly maintenance programs with methadone <strong>and</strong>buprenorphine, leads to reduction in HIV risk behavior among male <strong>and</strong> female IDUs,<strong>and</strong> is safe <strong>and</strong> effective <strong>for</strong> use by pregnant women (Metzger <strong>and</strong> Navaline, 2003; Demaanet al., 2002; Metzger et al., 2003; Ball et al., 1988 cited in Strathdee et al., 2006).A double-blind, double-dummy placebo-controlled r<strong>and</strong>omized controlled trial inMalaysia of 126 detoxified heroin-dependent patients were r<strong>and</strong>omly assigned to 24weeks of manual-guided drug counseling <strong>and</strong> maintenance either with naltrexone (43IDUs); buprenorphine (44 IDUs); or placebo. Buprenorphine was significantly associatedwith greater time to first heroin use <strong>and</strong> maximum consecutive abstinent days92 CHAPTER 4 PREVENTION FOR KEY AFFECTED POPULATIONS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!